美股详情

本页面由Tiger Fintech (Singapore) Pte. Ltd.提供服务

Medicus Pharma Ltd.

3.22

+0.27009.15%

盘前：3.420.2000+6.21%09:27 EDT

成交量：34.74万

成交额：110.07万

市值：5,130.57万

市盈率：- -

高：3.33

开：2.99

低：2.97

收：2.95

数据加载中...

总览公司新闻公告

公司资料

公司名字：

Medicus Pharma Ltd.

交易所：

NASDAQ

成立时间：

2015

员工人数：

- -

公司地址：

One First Canadian Place,Suite 3400,100 King Street West,Toronto,Ontario,Canada

官网：

http://www.medicuspharma.com

邮编：

M5X 1A4

电话：

- -

传真：

- -

简介：

Medicus Pharma Ltd.于2008年4月30日根据加拿大安大略省法律成立。他们是一家生物技术和生命科学公司，专注于加快新型和颠覆性治疗资产的临床开发项目。目前，他们正在开发一种产品SkinJectTM，用于治疗基底细胞癌。通过其全资子公司SkinJect, Inc.，他们专注于开发其许可的药物器械组合产品，使用新型可溶解微针阵列治疗非羊毛瘤皮肤癌。他们的联合候选产品是根据新药研究申请向美国食品和药物管理局（“FDA”）提交的阿霉素尖端装载D-MNA，受肿瘤科药物评估和注册中心（CDER）的监管。

董事

名称

职位

Raza Bokhari

Executive Chairman and Chief Executive Officer

Barry Fishman

Independent Director

Frank Lavelle

Independent Director

Larry Kaiser

Independent Director

Robert J. Ciaruffoli

Independent Lead Director

Sara R. May

Independent Director

William L. Ashton

Independent Director

Ajay Raju

Director

Cathy McMorris Rodgers

Director

股东

名称

职位

Raza Bokhari

Executive Chairman and Chief Executive Officer

Andrew Smith

Chief Operating Officer

James Quinlan

Chief Financial Officer

Carolyn Bonner

President

Edward Brennan

Chief Scientific Officer & Head of Research and development Program

Faisal Mehmud

Chief Medical Officer

{"basename":"/hans","ssrTDKData":{"titleTemplate":"%s - 老虎证券","title":"老虎证券全球投资理财平台| 一站式投资美股新股港股A股","description":"老虎证券助您一站式投资美股，新股，港股，A股等全球金融理财产品。新加坡华人最信赖的在线投资平台，现在加入即享低费用，24/5 无时差炒美股投资理财！","keywords":"老虎证券,老虎证券开户,老虎券商,老虎证券官网,老虎证券app,tigertrade老虎证券,股票,炒股,新加坡股票交易平台,投资,投资理财","social":{"ogDescription":"老虎证券助您一站式投资美股，新股，港股，A股等全球金融理财产品。新加坡华人最信赖的在线投资平台，现在加入即享低费用，24/5 无时差炒美股投资理财！","ogImage":"https://c1.itigergrowtha.com/portal5/static/media/og-logo.be62fbe1.png","ogUrl":"https://www-web.itiger.com/hans/stock/MDCX/company"},"companyName":"老虎证券"},"pageData":{"isMobile":false,"isTiger":false,"isTTM":true,"region":"SGP","license":"TBSG","edition":"fundamental","symbol":"MDCX","isAnalysisPage":false},"__swrFallback__":{"@#url:\"https://hq.skytigris.cn/stock_info/detail/global\",params:#delay:false,,method:\"POST\",data:#items:@#symbol:\"MDCX\",,,,,undefined,":{"symbol":"MDCX","market":"US","secType":"STK","nameCN":"Medicus Pharma Ltd.","latestPrice":3.22,"timestamp":1751486400000,"preClose":2.95,"halted":0,"volume":347407,"hourTrading":{"tag":"盘前","latestPrice":3.42,"preClose":3.22,"latestTime":"09:27 EDT","volume":24997,"amount":84780.71759290001,"timestamp":1751549270056},"delay":0,"floatShares":6964800,"shares":15933444,"eps":0,"marketStatus":"盘前交易","change":0.27,"latestTime":"07-03 09:29:38 EDT","open":2.99,"high":3.325,"low":2.965,"amount":1100703.3901579,"amplitude":0.122034,"askPrice":3.45,"askSize":899,"bidPrice":3.39,"bidSize":300,"shortable":3,"etf":0,"ttmEps":0,"tradingStatus":1,"nextMarketStatus":{"tag":"开盘","tradingStatus":2,"beginTime":1751549400000},"marketStatusCode":1,"adr":0,"listingDate":1731560400000,"exchange":"NASDAQ","adjPreClose":3.22,"preHourTrading":{"tag":"盘前","latestPrice":3.42,"preClose":3.22,"latestTime":"09:27 EDT","volume":24997,"amount":84780.71759290001,"timestamp":1751549270056},"postHourTrading":{"tag":"盘后","latestPrice":3.1693,"preClose":3.22,"latestTime":"19:40 EDT","volume":675,"amount":2182.0596,"timestamp":1751499635516},"volumeRatio":0.9433014993551327},"@#url:\"https://hq.skytigris.cn/stock_info/fundamental/all\",params:#delay:false,,method:\"POST\",data:#items:@#symbol:\"MDCX\",,,,,undefined,":{"symbol":"MDCX","floatShares":6964800,"roa":"--","roe":"--","lyrEps":0,"volumeRatio":0.9433014993551327,"shares":15933444,"dividePrice":0,"high":3.325,"amplitude":0.122034,"preClose":2.95,"low":2.965,"week52Low":1.8,"pbRate":"--","week52High":8.94,"institutionHeld":0,"latestPrice":3.22,"committee":-0.499583,"eps":0,"divideRate":0,"volume":347407,"delay":0,"ttmEps":0,"open":2.99,"prevYearClose":2.43,"fiveDayClose":2.73,"twentyDayClose":2.525,"sixtyDayClose":3.62},"@#url:\"stock.company.info\",,undefined,":{"stockCompanyProfile":{"companyId":1851846512,"yearFounded":2015,"address":"One First Canadian Place,Suite 3400,100 King Street West,Toronto,Ontario,Canada","zipCode":"M5X 1A4"},"stockCompanyDetail":{"websiteUrl":"http://www.medicuspharma.com","stockEarnings":[{"period":"1week","weight":0.1795},{"period":"1month","weight":0.2243},{"period":"3month","weight":-0.1413},{"period":"6month","weight":0.2829},{"period":"1year","weight":0.0387},{"period":"ytd","weight":0.3251}],"compareEarnings":[{"period":"1week","weight":0.022},{"period":"1month","weight":0.0468},{"period":"3month","weight":0.156},{"period":"6month","weight":0.0481},{"period":"1year","weight":0.1301},{"period":"ytd","weight":0.0586}],"compareStock":{"symbol":"SPY","name":"标普500ETF"},"description":"Medicus Pharma Ltd.于2008年4月30日根据加拿大安大略省法律成立。他们是一家生物技术和生命科学公司，专注于加快新型和颠覆性治疗资产的临床开发项目。目前，他们正在开发一种产品SkinJectTM，用于治疗基底细胞癌。通过其全资子公司SkinJect, Inc.，他们专注于开发其许可的药物器械组合产品，使用新型可溶解微针阵列治疗非羊毛瘤皮肤癌。他们的联合候选产品是根据新药研究申请向美国食品和药物管理局（“FDA”）提交的阿霉素尖端装载D-MNA，受肿瘤科药物评估和注册中心（CDER）的监管。","exchange":"NASDAQ","name":"Medicus Pharma Ltd.","nameEN":"Medicus Pharma Ltd."}},"@#url:\"https://hq.skytigris.cn/fundamental/company/manager/list\",params:#symbol:\"MDCX\",market:\"US\",,,undefined,":{"directors":[{"name":"Raza Bokhari","position":"Executive Chairman and Chief Executive Officer"},{"name":"Barry Fishman","position":"Independent Director"},{"name":"Frank Lavelle","position":"Independent Director"},{"name":"Larry Kaiser","position":"Independent Director"},{"name":"Robert J. Ciaruffoli","position":"Independent Lead Director"},{"name":"Sara R. May","position":"Independent Director"},{"name":"William L. Ashton","position":"Independent Director"},{"name":"Ajay Raju","position":"Director"},{"name":"Cathy McMorris Rodgers","position":"Director"}],"executives":[{"name":"Raza Bokhari","position":"Executive Chairman and Chief Executive Officer"},{"name":"Andrew Smith","position":"Chief Operating Officer"},{"name":"James Quinlan","position":"Chief Financial Officer"},{"name":"Carolyn Bonner","position":"President"},{"name":"Edward Brennan","position":"Chief Scientific Officer & Head of Research and development Program"},{"name":"Faisal Mehmud","position":"Chief Medical Officer"}]},"@#url:\"https://hq.skytigris.cn/fundamental/corporate_actions/details/MDCX\",params:#limit:5,,,undefined,":[],"@#url:\"https://hq.skytigris.cn/fundamental/dividend/history\",params:#symbol:\"MDCX\",market:\"US\",,,undefined,":[],"@#url:\"https://hq.skytigris.cn/fundamental/estimate/recommendation\",params:#symbol:\"MDCX\",market:\"US\",delay:false,,,undefined,":{"strongBuy":0,"buy":1,"hold":0,"sell":0,"strongSell":0,"meanLabel":"BUY","meanPercent":1,"analysts":3,"updateTime":1744689600000}}}